FindTrial
Sign In

Examination of the efficacy of "OKYURINGU" in ocular surface disease.

Examination of the efficacy of "OKYURINGU" in ocular surface disease. - Examination of the efficacy of "OKYURINGU"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030910
Enrollment
20
Registered
2018-02-01
Start date
2018-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BUT short type dry eye and chalasis

Interventions

Wear the &quot
OKYURINGU&quot
continuously for 24 weeks for 4 weeks.

Sponsors

Hokkaido University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: BUT short type dry eye and chalasis patients who are over 20 years old resistant to existing treatment such as eye drop treatment.

Exclusion criteria

Exclusion criteria: Those with eye diseases other than the above

Design outcomes

Primary

MeasureTime frame
Tear break up time at 24 hours, 1 week, 2 weeks, 3 weeks and 4 weeks after "OKYURINGU" wear—

Countries

Japan

Contacts

Public ContactTakeshi Ohguchi

Hokkaido University Ophthalmology

tohguchi@med.hokudai.ac.jp0117065944

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026